VALORANT Challengers League 2025 North America ACE: Stage 2
Upper Bracket R1
Winthrop University
United States
2025-05-20 23:20:00
2
-
0
Best of 3
terminé
Cubert Academy
United States
Jeux
Haven
13
-
8
Lotus
13
-
8
Joueur
kda
+/-
ACS
Clas. 3.0
KAST
ADR
hs%
Impact
fk
fd
F+/-
mk
Éch.
Embr.
49 / 28 / 11
+21
333.14
1.63
83.33%
216.12
30%
345
14
6
+8
13
1
1
40 / 26 / 16
+14
265.60
1.33
76.19%
169.52
33%
193
3
2
+1
13
1
1
29 / 24 / 31
+5
188.45
1.06
80.95%
130.83
36%
87
1
1
0
7
2
-
24 / 23 / 8
+1
163.38
0.85
69.05%
99.38
17%
135
4
2
+2
8
1
-
26 / 31 / 10
-5
179.69
0.83
71.43%
122.95
23%
128
4
5
-1
6
4
-
kda
+/-
ACS
Clas. 3.0
KAST
ADR
hs%
Impact
fk
fd
F+/-
mk
Éch.
Embr.
33 / 32 / 14
+1
220.64
1.16
71.43%
147.14
42%
255
6
2
+4
9
4
3
30 / 37 / 10
-7
208.76
0.93
73.81%
126.31
31%
148
6
5
+1
6
2
-
26 / 31 / 13
-5
178.98
0.91
64.29%
116.05
26%
143
2
3
-1
8
4
1
25 / 34 / 10
-9
169.45
0.82
59.52%
113.38
26%
84
1
9
-8
6
2
-
18 / 34 / 14
-16
126.05
0.64
64.29%
85.64
29%
51
1
7
-6
2
4
-
Winthrop University
Classement Mondial: #-
Bookmaker
WU
vs
Cubert Acd
Matchs passés
Date
Match
Événement
Matchs passés
Date
Match
Événement
2025-03-18 22:18:44
Cubert Acd
0
-
2
M80
VALORANT Challengers 2025 North America: Stage 1
2025-03-17 20:06:09
Cubert Acd
2
-
1
envy
VALORANT Challengers 2025 North America: Stage 1
2025-03-13 22:50:35
Cubert Acd
1
-
2
WU
VALORANT Challengers 2025 North America: Stage 1
2025-03-10 23:22:00
Cubert Acd
2
-
1
QoR
VALORANT Challengers 2025 North America: Stage 1
2025-02-19 23:23:26
Cubert Acd
2
-
0
M80
VALORANT Challengers 2025 North America: Stage 1
2025-02-18 00:01:39
Cubert Acd
2
-
1
LNDR
VALORANT Challengers 2025 North America: Stage 1
2025-02-11 20:58:37
Cubert Acd
0
-
2
envy
VALORANT Challengers 2025 North America: Stage 1
2025-02-04 21:12:47
Cubert Acd
2
-
0
SaD Esp
VALORANT Challengers 2025 North America: Stage 1
MVP
Informations sur l'événement
VALORANT Challengers League 2025 North America ACE: Stage 2
2025-04-09 00:00:00
-
2025-05-30 00:00:00
60
Matchs
$49,500
Cagnotte
B-Tier
Niveau
Équipe
Matchs
Rounds
RD